Absence of defects in SPECT thallium-201 myocardial images in patients with systemic hypertension and left

M P Cecil1, W C Pilcher, R L Eisner

  • 1Carlyle Fraser Heart Center, Emory/Crawford Long Hospital, Department of Medicine (Cardiology), Atlanta, Georgia 30365.

Insights

Hypertension and left ventricular hypertrophy do not cause abnormal thallium-201 SPECT myocardial perfusion imaging. This study found normal thallium-201 distribution in patients with hypertension, debunking artifact concerns.

Area of Science:

  • Cardiology
  • Nuclear Medicine
  • Radiology

Background:

  • Hypertension is common in patients undergoing myocardial perfusion imaging.
  • Previous studies suggested hypertension-induced left ventricular hypertrophy can cause artifacts in thallium-201 SPECT imaging, mimicking myocardial infarction.
  • These artifacts, specifically diminished lateral/septal count ratios, were reported in up to 35% of patients with end-stage renal disease and left ventricular hypertrophy.

Purpose of the Study:

  • To evaluate myocardial SPECT thallium-201 distribution in a broader group of patients with hypertension-related left ventricular hypertrophy.
  • To determine the prevalence of abnormal thallium-201 SPECT studies in this patient population.
  • To compare the lateral/septal count ratio between hypertensive patients with left ventricular hypertrophy and normal subjects.

Main Methods:

  • Compared average thallium-201 counts in myocardial regions of male patients with hypertension and left ventricular hypertrophy (n=16) to normal male subjects (n=49).
  • Focused analysis on the lateral and septal walls to calculate the lateral/septal count ratio.
  • Assessed stress and delayed imaging for abnormalities, defining defects as ratios more than 2.0 standard deviations below normal limits.

Main Results:

  • The mean lateral/septal wall count ratio was 4.4% lower in the hypertensive group (1.09 +/- 0.07) compared to the normal group (1.14 +/- 0.07; p < 0.01).
  • At 3-hour delay, the lateral/septal count ratio was similar between the study group (1.06 +/- 0.09) and the normal group (1.08 +/- 0.06; p = NS).
  • Crucially, no patient exhibited a defect, and all thallium-201 studies were interpreted as normal.

Conclusions:

  • Myocardial thallium-201 distribution is normal in patients with left ventricular hypertrophy resulting from hypertension.
  • Hypertension-induced left ventricular hypertrophy does not lead to clinically significant artifacts on thallium-201 SPECT myocardial perfusion imaging.
  • The findings suggest that previously reported artifacts may be overestimated or specific to certain patient subgroups.

Related Concept Videos

Imaging Studies for Cardiovascular System III: X-Ray01:20

Imaging Studies for Cardiovascular System III: X-Ray

The most common cardiovascular diagnostic test is an X-ray. It produces images of the heart, blood vessels, and adjacent structures.
Definition and Purpose
An X-ray, or radiograph, is a non-invasive method that uses ionizing radiation to take images of internal structures. It is mainly used in cardiac imaging to examine the heart, lungs, and major blood vessels, aiming to identify abnormalities in the heart's size, shape, and position, such as heart failure, congenital defects, and vascular...
Imaging Studies for Cardiovascular System V: CT01:28

Imaging Studies for Cardiovascular System V: CT

Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...